Opko Health, Inc.
Opko Health, Inc. is a multinational biopharmaceutical and diagnostics company, founded in 2007 by Phillip Frost, MD. The company’s mission is to develop innovative products across the healthcare spectrum to improve patient care and enable better outcomes. To pursue this goal, they focus on four core product categories: Pharmaceuticals, Diagnostics, Imaging and BioReference Laboratories. Their pharmaceutical products are primarily aimed at hormone deficiencies and other medical conditions like prostate cancer or diabetes; their diagnostic products leverage novel technologies to identify diseases early; their imaging solutions facilitate more effective screening; and their BioReference Laboratories provide an array of clinical testing services. Opko’s diagnostics portfolio also includes Point-of-Care tests for the diagnosis of infectious disease as well as home-use kits for therapeutic drug monitoring. With operations in over 30 countries on six continents, the company has recently invested into research towards artificial intelligence for image analysis in order to accompany its current health offerings with more precise diagnostic tools.
Headquarters
4400 BISCAYNE BLVD, MIAMI, FL 33137